AZD5315

AZD5315 · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD5315, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) [Phase 1, Phase 2]